Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 49 citing articles:

Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Bilgin Osmanodja, Simon Ronicke, Klemens Budde, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2565-2565
Open Access | Times Cited: 76
Adverse Reactions of COVID-19 Vaccines: A Scoping Review of Observational Studies
Inge Dhamanti, Auliya A. Suwantika, Amirah Adlia, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 609-618
Open Access | Times Cited: 44
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 39
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines
Feargal J. Ryan, Todd S. Norton, Conor McCafferty, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 3, pp. 100971-100971
Open Access | Times Cited: 26
A potential association between obesity and reduced effectiveness of COVID‐19 vaccine‐induced neutralizing humoral immunity
Arwa A. Faizo, Fadi S. Qashqari, Sherif A. El‐Kafrawy, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 36
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)
David A. Jolliffe, Sian Faustini, Hayley Holt, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1601-1601
Open Access | Times Cited: 28
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Bilgin Osmanodja, Simon Ronicke, Klemens Budde, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review
Cangcang Fu, Nan Lin, Jihua Zhu, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 996-996
Open Access | Times Cited: 14
Comparative Analysis of SARS-CoV-2 Antibody Responses across Global and Lesser-Studied Vaccines
José Víctor Zambrana, Carlos Saenz, Hannah E. Maier, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 326-326
Open Access | Times Cited: 4
Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients
Nuttasith Larpparisuth, Kritsada Pongsakornkullachart, Nartsiri Ratchawang, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42291-e42291
Open Access
Incidence of dynamic seroconversion in subjects received the first dose of the SARS-COV-2 vaccine (AstraZeneca, Moderna and Pfizer) in Kinshasa, Democratic Republic of Congo: prospective cohort study
Eric Kasongo Mukenge, Blaise Matondo Manzambi Sumbu, Aliocha Natuhoyila Nkodila, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds
Maxence Meyer, Florentin Constancias, Claudia Worth, et al.
GeroScience (2022) Vol. 44, Iss. 3, pp. 1229-1240
Open Access | Times Cited: 18
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
Poor immune response to inactivated COVID-19 vaccine in patients with hypertension
Lei Yang, Tingting Zeng, Yang Li, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
COVID‐19, obesity, and immune response 2 years after the pandemic: A timeline of scientific advances
Mayara Belchior‐Bezerra, Rafael Silva Lima, Nayara I. Medeiros, et al.
Obesity Reviews (2022) Vol. 23, Iss. 10
Open Access | Times Cited: 15
A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers
Tesfaye Gelanew, Andargachew Mulu, Markos Abebe, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 859-859
Open Access | Times Cited: 13
COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19
Jung Yeon Heo, Yu Bin Seo, Eun Jin Kim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Factors Associated with Adverse Events Following the First Dose of COVID-19 Immunization in Indonesia
Siti Fadlilah, Deden Iwan Setiawan, Muflih Muflih, et al.
Korean Journal of Adult Nursing (2022) Vol. 34, Iss. 3, pp. 249-249
Open Access | Times Cited: 12
Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity
M. D’Souza, Alexa Keeshan, Christopher A. Gravel, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth
Nir Kugelman, Chen Nahshon, Pninit Shaked‐Mishan, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2022) Vol. 274, pp. 148-154
Open Access | Times Cited: 11
The use of adenoviral vectors in gene therapy and vaccine approaches
Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, et al.
Genetics and Molecular Biology (2022) Vol. 45, Iss. 3 suppl 1
Open Access | Times Cited: 9
Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects
Katharine Valéria Saraiva Hodel, Ananda Fonseca, Islania Almeida Brandão Barbosa, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 13, pp. 1651-1663
Closed Access | Times Cited: 1
Reactivity of anti‐SARS‐CoV‐2 antibodies in Serbian voluntary blood donors
Milomir Bezanovic, Zorana Budakov Obradovic, Nevenka Bujandrić, et al.
Transfusion Medicine (2024) Vol. 34, Iss. 3, pp. 200-210
Closed Access | Times Cited: 1
Serological Evaluation of Antibody Titers After Vaccination Against COVID-19 in 18-44-Year-Old Individuals at a Tertiary Care Center
Rachita Nanda, Prishni Gupta, A. Giri, et al.
Cureus (2023)
Open Access | Times Cited: 4
Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)
David A. Jolliffe, Sian Faustini, Hayley Holt, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top